Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 20 November 2017

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Laparoscopic gastric bypass vs laparoscopic adjustable gastric banding

Laparoscopic gastric bypass provides a higher excess weight loss at 18 months, compared with laparoscopic adjustable gastric banding, find doctors in the October issue of the Journal of the American College of Surgeons.

News image

fiogf49gjkf04

Obesity is an increasing concern.

The most common surgical procedures for obesity are the gastric bypass and the adjustable gastric banding. However, the indications and results of these techniques are unclear.

In the United States gastric bypass is regarded as the procedure which offers the best weight-loss outcome, but European surgeons prefer laparoscopic adjustable gastric banding.

Patients in the laparoscopic gastric bypass group were significantly heavier.
Journal of the American College of Surgeons

In this study, doctors from Switzerland and United States compared 2 groups of patients.

The first group included 805 obese patients from Switzerland who had a laparoscopic Swedish adjustable gastric banding (LAGB) performed between 1997 and 2001. The second group included 456 patients from the United States who had a laparoscopic gastric bypass (LGB) performed between 1998 and 2001.

The research team found that the patients in the LGB group were significantly heavier than those in the LAGB group.

However, they determined that postoperative stay after LGB was significantly less than after LAGB. This may be related to health system differences between the 2 countries.

The team identified 9 major intraoperative complications in the LGB group and 10 in the LAGB group.

They also found that 9 patients in the LGB group and 24 in the LAGB group required a conversion to another procedure. The primary cause of conversion was related to the obesity. In the first 30 days following surgery the team found there were no deaths in the LAGB group and 2 in the LGB group. However, there were 37 late major complications in the LGB group and 74 in the LAGB group.

After adjusting for preoperative weight, the team found that the mean excess weight loss (EWL) at 3 months was 36% after LGB versus 15% after LAGB. At 6 months EWL was 52% in the LGB group and 23% in the LAGB group, at 12 months 67% and 33%, and at 18 months 75% and 40%.

Dr Laurent Biertho's team concluded, "LGB provides a higher EWL at 18 months, compared with LAGB…this holds for all ranges of preoperative BMI".

"Both procedures can produce an EWL above 50%, but this criterion is met faster after LGB".

"The best indication for the two procedures is still unclear and probably depends on the patient's preoperative BMI, eating habits, and associated morbidities".

J Am Coll Surg 2003; 197(4): 536-45
03 October 2003

Go to top of page Email this page Email this page to a colleague

 20 November 2017 
Barriers to hepatitis C treatment
 20 November 2017 
Socioeconomic characteristics in diverticular disease
 20 November 2017 
Endoscopic indices of disease activity for Crohn’s
 17 November 2017 
Food elimination diets for treatment of adults with eosinophilic esophagitis
 17 November 2017 
PPI use and cognitive function in women
 17 November 2017 
Predicting microscopic colitis
 16 November 2017 
NAFLD-hepatocellular carcinoma and survival after orthotopic liver transplant
 16 November 2017 
Prepregnancy obesity and severe maternal morbidity
 16 November 2017 
Celiac disease screening in adult first-degree relatives
 15 November 2017 
Breastfeeding and the risk of IBD
 15 November 2017 
Medication nonadherence and health care costs
 15 November 2017 
Predicting recurrence after curative rectal cancer surgery
 14 November 2017 
HBV/HCV coinfection and cirrhosis
 14 November 2017 
Sexual dysfunction after rectal cancer surgery
 14 November 2017 
Eosinophilic gastroenteritis and colitis
 13 November 2017 
GI bleeding in patients taking non–vitamin K antagonist oral anticoagulants
 13 November 2017 
Genetic polymorphisms, fatty acids and ulcerative colitis
 13 November 2017 
Flares after immunomodulator withdrawal in Crohn's
 10 November 2017 
Thiopurines vs TNF and lymphoma risk in IBD
 10 November 2017 
Drug monitoring of anti-tumour necrosis factor therapy in IBD
 10 November 2017 
Treatment decisions for older patients with colorectal cancer
 09 November 2017 
Quality standards in upper gastrointestinal endoscopy
 09 November 2017 
Irradiated rectal cancer and chemoradiotherapy
 09 November 2017 
Environmental factors and IBD
 08 November 2017 
Prophylaxis of spontaneous bacterial peritonitis
 08 November 2017 
Optimal management of postoperative Crohn's disease
 07 November 2017 
Community Screening for Helicobacter pylori
 07 November 2017 
Early readmission in IBD patients
 07 November 2017 
Mesocolic excision for colon cancer
 06 November 2017 
Food elimination diet for children with eosinophilic esophagitis
 06 November 2017 
Biologic agents and obesity in children with IBD
 06 November 2017 
Liver cancer burden despite extensive use of antiviral agents
 03 November 2017 
Statins and mortality in chronic viral hepatitis
 03 November 2017 
Propofol for outpatient colonoscopy
 03 November 2017 
Asthma and IBD development
 02 November 2017 
Diverticulitis and emergency department burden
 02 November 2017 
Rural residence and risk of IBD
 02 November 2017 
Sexual functioning in Hep C
 01 November 2017 
Heartburn relief in adolescents with GERD
 01 November 2017 
Autoimmune pancreatitis in children
 31 October 2017 
Follow-up of positive results on fecal blood tests
 31 October 2017 
Surveillance in ulcerative colitis and Crohn’s disease
 30 October 2017 
Local recurrence after curative rectal cancer surgery
 30 October 2017 
Low-flow ascites pump in refractory cirrhosis
 30 October 2017 
Medical therapy of patients with pediatric-onset IBD
 27 October 2017 
NAFLD in advanced fibrosis in the USA
 27 October 2017 
Early readmission in cirrhosis after bacterial infections
 26 October 2017 
Predicting response to anti-TNF therapy in Crohn's
 26 October 2017 
Conversion to open laparotomy in rectal cancer
 25 October 2017 
Conversion of colonoscopy to sigmoidoscopy
 25 October 2017 
Fecal microbiota transplantation
 25 October 2017 
Rifaximin and survival in hepatic encephalopathy
 24 October 2017 
Eosinophilic esophagitis with swallowed topical corticosteroids
 24 October 2017 
Meta-analysis in nutritiona research
 23 October 2017 
NAFLD-related hepatocellular carcinoma in liver resection
 23 October 2017 
Outcome of hepatic sarcoidosis
 20 October 2017 
Conversion of planned colonoscopy to sigmoidoscopy
 20 October 2017 
Hospital readmissions reduction program
 19 October 2017 
Surgical anastomosis at 1-year colorectal cancer surveillance
 19 October 2017 
Fecal immunochemical tests in colorectal cancer screening

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us